Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours ; volume:13 ; number:1 ; day:13 ; month:3 ; year:2023 ; pages:1-10 ; date:12.2023
Scientific reports ; 13, Heft 1 (13.3.2023), 1-10, 12.2023
- Creator
-
O’Haire, Sophie
Franchini, Fanny
Kang, Yoon-Jung
Steinberg, Julia
Canfell, Karen
Desai, Jayesh
Fox, Stephen
IJzerman, Maarten
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-31055-3
- URN
-
urn:nbn:de:101:1-2408070920434.105627319676
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:04 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- O’Haire, Sophie
- Franchini, Fanny
- Kang, Yoon-Jung
- Steinberg, Julia
- Canfell, Karen
- Desai, Jayesh
- Fox, Stephen
- IJzerman, Maarten
- SpringerLink (Online service)
Other Objects (12)
Pan-cancer whole-genome analyses of metastatic solid tumours
Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
Pan-cancer patterns of DNA methylation
Pan-cancer analysis of whole genomes
Pan-cancer analysis of whole genomes
Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial
A pan-cancer analysis of synonymous mutations
Systematic characterization of pan‐cancer mutation clusters
Pan-cancer whole-genome analyses of metastatic solid tumours
Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
Pan-cancer patterns of DNA methylation
Pan-cancer analysis of whole genomes
Pan-cancer analysis of whole genomes
Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial
A pan-cancer analysis of synonymous mutations
Systematic characterization of pan‐cancer mutation clusters
Pan-cancer whole-genome analyses of metastatic solid tumours
Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
Pan-cancer patterns of DNA methylation
Pan-cancer analysis of whole genomes
Pan-cancer analysis of whole genomes
Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial
A pan-cancer analysis of synonymous mutations